Home › Funds › Rock Springs Capital Management LP › RARE
Rock Springs Capital Management LP position in RARE
ULTRAGENYX PHARMACEUTICAL IN · Health Care
Rock Springs Capital Management LP reported holding 925,089 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q3 2026 13F filing — a position valued at US$13.9M, representing 0.75% of its reported portfolio and ranking #43 among its reported holdings. Rock Springs Capital Management LP has disclosed RARE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rock Springs Capital Management LP's RARE position evolved
Rock Springs Capital Management LP first disclosed a stake in RARE in Q3 2023 at 1,476,441 shares (US$52.6M). The position peaked in Q3 2024 at 1,978,272 shares, worth US$109.9M. Across 13 filings, Rock Springs Capital Management LP increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 925,089 shares valued at US$13.9M — a reduction of -42,766 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.48M | $52.64M | New |
| Q4 2023 | 1.75M | $83.88M | Add |
| Q1 2024 | 1.77M | $82.87M | Add |
| Q2 2024 | 1.92M | $79.08M | Add |
| Q3 2024 | 1.98M | $109.89M | Add |
| Q4 2024 | 1.74M | $73.19M | Reduce |
| Q1 2025 | 1.39M | $50.49M | Reduce |
| Q2 2025 | 1.39M | $50.58M | Hold |
| Q3 2025 | 1.25M | $37.49M | Reduce |
| Q4 2025 | 1.27M | $29.15M | Add |
| Q1 2026 | 1.22M | $25.53M | Reduce |
| Q2 2026 | 967.86K | $32.32M | Reduce |
| Q3 2026 | 925.09K | $13.90M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RARE and 13F data
RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 21 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$128.2M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M), Bellevue Group AG (US$66.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RARE
- RTW INVESTMENTS, LP 8.53M sh · $128.20M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 2.85M sh · $95.09M · Q2 2026
- Bellevue Group AG 1.98M sh · $66.20M · Q2 2026
- MPM BioImpact LLC 1.42M sh · $47.35M · Q2 2026
- Nantahala Capital Management, LLC 2.34M sh · $35.16M · Q3 2026
More on Rock Springs Capital Management LP
FAQ
How long has Rock Springs Capital Management LP held RARE?
Rock Springs Capital Management LP has disclosed RARE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Rock Springs Capital Management LP's current position in RARE?
As of Q3 2026, Rock Springs Capital Management LP holds 925.09K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $13.90M, representing 0.75% of its reported portfolio and ranking #43.
Has Rock Springs Capital Management LP been buying or selling RARE?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in RARE. The position peaked in Q3 2024 at 1.98M shares.
Which other funds hold RARE?
Other major institutional holders of RARE include RTW INVESTMENTS, LP, FRONTIER CAPITAL MANAGEMENT CO LLC, Bellevue Group AG, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.